- £78.20bn
- £93.38bn
- £32.67bn
REG - Official List - Official List Notice
AnnouncementREG - Stock Exch Notice - Admission to Trading - 23/12/2024
AnnouncementREG - GSK PLC - Block Listing Application
AnnouncementREG - GSK PLC - Headline results from phase III FIRST trial
AnnouncementREG - GSK PLC - EMA grants PRIME Designation for GSK’227
AnnouncementREG - GSK PLC - Jemperli receives US FDA breakthrough designation
AnnouncementREG - GSK PLC - Jemperli receives positive CHMP opinion
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Overall survival data presented for Blenrep
AnnouncementREG - GSK PLC - Blenrep combination China filing acceptance
AnnouncementREG - GSK PLC - Nucala COPD submission accepted by US FDA
AnnouncementREG - GSK PLC - Zhifei China collaboration revised and extended
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - GSK liquid meningitis vaccine authorised in EU
AnnouncementREG - GSK PLC - Blenrep combinations accepted for US FDA review
AnnouncementREG - GSK PLC - Japan approves first RSV vaccine for adults 50-59
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
Announcement